Dorsey Wright & Associates Cerus Corp Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 02, 2019
SELL
$4.51 - $6.6 $6,643 - $9,721
-1,473 Closed
0 $0
Q1 2019

Apr 04, 2019
SELL
$5.16 - $6.85 $7,600 - $10,090
-1,473 Reduced 50.0%
1,473 $9,000
Q4 2018

Jan 07, 2019
BUY
$4.89 - $7.16 $2,400 - $3,515
491 Added 20.0%
2,946 $15,000
Q3 2018

Oct 12, 2018
BUY
$6.89 - $7.78 $16,914 - $19,099
2,455 New
2,455 $18,000

Others Institutions Holding CERS

# of Institutions
155
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $278M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email